2025-08-01 2026-07-31 2026-07-31 false 10890945 Pharmaskin UK Limited 86900Other human health activities iso4217:GBP xbrli:pure 108909452025-08-01 108909452026-07-31 108909452025-08-01 2026-07-31 10890945bus:Micro-entities2025-08-01 2026-07-31 10890945bus:AuditExempt-NoAccountantsReport2025-08-01 2026-07-31 10890945bus:FullAccounts2025-08-01 2026-07-31 10890945core:WithinOneYear2026-07-31 10890945core:AfterOneYear2026-07-31 10890945core:WithinOneYear2025-08-01 2026-07-31 10890945core:AfterOneYear2025-08-01 2026-07-31 10890945core:CurrentFinancialInstruments2026-07-31 10890945core:Non-currentFinancialInstruments2026-07-31 10890945core:CurrentFinancialInstruments2025-08-01 2026-07-31 10890945core:Non-currentFinancialInstruments2025-08-01 2026-07-31 10890945core:LandBuildings2025-08-01 2026-07-31 10890945core:FurnitureFittings2025-08-01 2026-07-31 10890945core:OfficeEquipment2025-08-01 2026-07-31 10890945core:Vehicles2025-08-01 2026-07-31 10890945core:PlantMachinery2025-08-01 2026-07-31 10890945core:OtherPropertyPlantEquipment2025-08-01 2026-07-31 10890945core:LandBuildings2026-07-31 10890945core:PlantMachinery2026-07-31 10890945core:Vehicles2026-07-31 10890945core:FurnitureFittings2026-07-31 10890945core:OfficeEquipment2026-07-31 10890945core:OtherPropertyPlantEquipment2026-07-31 10890945core:Right-of-useAssets2025-08-01 2026-07-31 10890945core:Right-of-useAssets2026-07-31 10890945core:Goodwill2025-08-01 2026-07-31 10890945core:PatentsTrademarksLicencesConcessionsSimilar2025-08-01 2026-07-31 10890945core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-08-01 2026-07-31 10890945core:OtherResidualIntangibleAssets2025-08-01 2026-07-31 10890945core:Goodwill2026-07-31 10890945core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-07-31 10890945core:PatentsTrademarksLicencesConcessionsSimilar2026-07-31 10890945core:OtherResidualIntangibleAssets2026-07-31 10890945dpl:CostSales2025-08-01 2026-07-31 10890945dpl:AdministrativeExpenses2025-08-01 2026-07-31 10890945dpl:DistributionCosts2025-08-01 2026-07-31108909452024-08-01 108909452025-07-31 108909452024-08-01 2025-07-31 10890945core:WithinOneYear2025-07-31 10890945core:AfterOneYear2025-07-31 10890945core:CurrentFinancialInstruments2025-07-31 10890945core:Non-currentFinancialInstruments2025-07-31 10890945core:LandBuildings2025-07-31 10890945core:PlantMachinery2025-07-31 10890945core:Vehicles2025-07-31 10890945core:FurnitureFittings2025-07-31 10890945core:OfficeEquipment2025-07-31 10890945core:OtherPropertyPlantEquipment2025-07-31 10890945core:Right-of-useAssets2025-07-31 10890945core:Goodwill2025-07-31 10890945core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-07-31 10890945core:PatentsTrademarksLicencesConcessionsSimilar2025-07-31 10890945core:OtherResidualIntangibleAssets2025-07-31 10890945dpl:AdministrativeExpenses2024-08-01 2025-07-3110890945bus:Director12025-08-01 2026-07-3110890945bus:PrivateLimitedCompanyLtd2025-08-01 2026-07-31
Pharmaskin UK Limited
Unaudited Financial Statements
for the year ended 31 July 2026
Company registration number 10890945
(England and Wales)

Company Information

For the year ended 31 July 2026
Director Hui, Sylvia Wan Ling

Registered office 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Registered number 10890945

Accountant Pharmaskin Uk Limited
71-75 Shelton Street
london
wc2h9jq

Statement of Financial Position

As at 31 July 2026
2026
2025
£
£
£
£
Current assets
20,234
20,932
Creditors amounts falling due within one year
(1,115)
(1,253)
Net current assets (liabilities)
19,119
19,679
Total assets less current liabilities
19,119
19,679
Net assets (liabilities)
19,119
19,679
Capital and reserves
19,119
19,679

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 0 (2025: 0).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the director on 30 August 2026 and are signed on its behalf by:

Hui, Sylvia Wan Ling
Hui, Sylvia Wan Ling
Director

Company registration number 10890945